Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Handheld US Device to Verify Vascular Cannulation

NCT: NCT07722065 · ENROLLING_BY_INVITATION

NCT IDNCT07722065
StatusENROLLING_BY_INVITATION
Start Date2026-08
Completion2027-12
SponsorAlok Moharir (OTHER)
First posted
Last updated

Brief Summary

This a prospective study in pediatric patients undergoing surgery and requiring placement of an intravenous cannula. This will be a novel study to assess whether a handheld compatible cardiac ultrasound device (Lumify) can be used to quickly and reliably verify successful vascular cannulation in pediatric patients using the rapid atrial swirl sign (RASS) technique. As emerging technologies have made hand-held ultrasound devices more versatile, portable, and cheaper, it will be important to prove if they can be as accurate as traditional ultrasound devices for their intended focused point-of-care functions. If the handheld device is deemed efficacious, it will allow the use of a portable hand-held device rather than the more difficult to transport devices (Sonosite).

Frequently Asked Questions

What is Handheld US Device to Verify Vascular Cannulation?

Handheld US Device to Verify Vascular Cannulation is a clinical trial registered under NCT07722065. Current status: ENROLLING_BY_INVITATION.

What is the status of NCT07722065?

The current status of NCT07722065 (Handheld US Device to Verify Vascular Cannulation) is: ENROLLING_BY_INVITATION.

When did Handheld US Device to Verify Vascular Cannulation start?

Handheld US Device to Verify Vascular Cannulation started on 2026-08.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.